Sergei Gryaznov
2023
In 2023, Sergei Gryaznov earned a total compensation of $894.7K as Chief Scientific Officer at MAIA Biotechnology, a 16% increase compared to previous year.
Compensation breakdown
| Option Awards | $477,415 |
|---|---|
| Salary | $363,000 |
| Other | $54,334 |
| Total | $894,749 |
Gryaznov received $477.4K in option awards, accounting for 53% of the total pay in 2023.
Gryaznov also received $363K in salary and $54.3K in other compensation.
Rankings
In 2023, Sergei Gryaznov's compensation ranked 1,333rd out of 2,978 executives tracked by ExecPay. In other words, Gryaznov earned more than 55.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,333 out of 2,978 | 55th |
Division Manufacturing | 798 out of 1,637 | 51st |
Major group Chemicals And Allied Products | 528 out of 906 | 42nd |
Industry group Drugs | 515 out of 869 | 41st |
Industry Pharmaceutical Preparations | 357 out of 627 | 43rd |
Source: SEC filing on April 16, 2024.
Gryaznov's colleagues
We found four more compensation records of executives who worked with Sergei Gryaznov at MAIA Biotechnology in 2023.